The article gives away the game here:
>> But Doblin still envisions treatment centres sprouting up around the world — he predicts that more than 6,000 will emerge in the United States alone — where people with PTSD and other psychiatric illnesses can safely and legally use MDMA and other psychedelics under the guidance of therapists. Beyond this, he hopes ultimately for full legalization that would allow anyone to take the drugs however they wish. “MAPS has been the beacon to kind of take on this work,” says neuroscientist Amy Kruse, who is chief investment officer at venture capital firm Satori Neuro and is based in Annapolis, Maryland. “There are many people that can benefit from this treatment, and I think it shows a pathway for the potential rescheduling of other molecules.”
They are breathless in anticipation of a billion dollar industry. They even include this link:
https://www.bloomberg.com/press-releases/2022-07-18/psychede...